Literature DB >> 10431921

A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs.

D G Green1, N V Kapousta-Bruneau.   

Abstract

The origins of the a- and b-wave of the ERG were studied using simultaneous recordings made across the receptor layer and the full thickness of a piece of isolated albino rat retina. An inwardly directed current flowing across the rod outer segments was eliminated from the recording when postsynaptic activity was blocked with cobalt or when current source density measurements were made along the length of the outer segments. Rod photovoltages were inferred by removing extraneous field potentials from the recordings made across the photoreceptor layer. The spatial properties of the photovoltage indicates the responses came from an area about 100 microm in diameter. The glutamate analog. APB, which blocks depolarizing bipolar cells, eliminated the b-wave but left the a-wave unaffected. The ERG component due to depolarizing bipolar cells was inferred by subtracting recordings obtained before and after APB. After treatment with APB a slow component remained. This component was completely blocked by barium (200 microM), which blocks potassium channels on Müller cells. Barium had virtually no effect on low-intensity photovoltages but did affect the amplitude and shape of the saturated responses. Barium increased the amplitude of the component of the ERG which underlies the b-wave. It was concluded that the depolarizing bipolar cells directly generate the b-wave of the ERG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431921     DOI: 10.1017/s0952523899164125

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  46 in total

1.  The negative ERG is not synonymous with nightblindness.

Authors:  G W Cibis; K M Fitzgerald
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Comparison of conventional ERG parameters and high-intensity A-wave analysis in a clinical setting.

Authors:  Michael F Marmor; Alexandra Serrato; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

3.  Light responses and light adaptation in rat retinal rods at different temperatures.

Authors:  S Nymark; H Heikkinen; C Haldin; K Donner; A Koskelainen
Journal:  J Physiol       Date:  2005-07-21       Impact factor: 5.182

4.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.

Authors:  John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  Exp Eye Res       Date:  2010-11-20       Impact factor: 3.467

Review 5.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

6.  Ex vivo ERG analysis of photoreceptors using an in vivo ERG system.

Authors:  Frans Vinberg; Alexander V Kolesnikov; Vladimir J Kefalov
Journal:  Vision Res       Date:  2014-06-21       Impact factor: 1.886

7.  The scotopic threshold response of the dark-adapted electroretinogram of the mouse.

Authors:  Shannon M Saszik; John G Robson; Laura J Frishman
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

8.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

9.  In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.

Authors:  Felipe Piacentini Paes de Almeida; Juliana Barbosa Saliba; Jefferson Augusto Santana Ribeiro; Rubens Camargo Siqueira; Sílvia L Fialho; Armando Silva-Cunha; Rodrigo Jorge; Andre Messias
Journal:  Doc Ophthalmol       Date:  2015-11-17       Impact factor: 2.379

10.  Intra-retinal visual cycle required for rapid and complete cone dark adaptation.

Authors:  Jin-Shan Wang; Maureen E Estevez; M Carter Cornwall; Vladimir J Kefalov
Journal:  Nat Neurosci       Date:  2009-02-01       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.